CH le Vinatier
Bron, 69500, France
Location status: Recruiting
NCT Number: NCT06284382
This prospective, double-blind, parallel-group controlled trial aims to investigate the consequence of early trauma on dopamine release evoked by positive valence odors.
Interested in participating?
Request Info18 year–30 year
All sexes
Interventional
Not applicable
Bron, 69500, France
Location status: Recruiting
The occurrence of early trauma has been linked to alterations in the development of emotion regulation circuits and functional brain connectivity (particularly in the dorsolateral prefrontal cortex - DLPFC), the dopaminergic response to stress and an alteration in hedonicity (including olfactory hedonicity), which can lead to the onset of psychiatric disorders such as anxiety or depression.
However, few studies have investigated the influence of early trauma on the release of dopamine (DA) evoked by odors with a positive emotional valence. Yet hedonicity is a key component of olfaction, as a positive odor leads to reinforced behavior in areas such as food intake and social interaction. This reinforcement process is thought to be underpinned by the very close link between the olfactory system (olfactory tubercle), the emotional regulation system (DLPFC) and the reward system (striatum), including the release of DA.
The aim of the study is to investigate the influence of early trauma on DAergic transmission evoked by odorants with a positive emotional valence.
To this end, 30 participants will be recruited and divided into two groups: those with early trauma and those without, according to their score on the Childhood Trauma Questionnaire. They will undergo an MRI-PET scan during which they will be exposed to pleasant odors. Subcortical dopaminergic transmission will be analyzed using the PET activity of [11C]Raclopride (a D2 receptor antagonist).
Investigators hypothesize that early trauma resulting in abnormal cortico-subcortical and cortico-cortical connectivity would lead to a deficit in the hedonic appreciation of a pleasant odor, associated with a reduction in DAergic reactivity evoked in the reward system.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the "presence of early trauma" arm, 15 participants are recruited based on a high Childhood Trauma Questionnaire total score.
In the "absence of early trauma" arm, 15 participants are recruited based on a low Childhood Trauma Questionnaire total score.
Time frame: 24 months
Subcortical dopaminergic transmission will be analyzed, using [11C]raclopride PET activity (D2 receptor antagonist)
Time frame: 24 months
The pleasantness of the odors presented will be assessed on a scale of 1 to 9.
Time frame: 24 months
Resting-state functional connectivity assessed with fMRI.
Time frame: 24 months
Effective brain connectivity will be assessed using a dual-coil TMS protocol that stimulates the motor cortex and dorsolateral prefrontal cortex during odor presentation. Measurement of the amplitude of the motor response reflects the connectivity between these two regions of interest.
Contact information is provided by the study sponsor or research team.
FILIPE GALVAO
CONTACT
VERONIQUE VIAL
CONTACT
Hôpital le Vinatier
Other
Consequence of Early Trauma on Odor Hedonics Appreciation and DOpamine Release
Acronym: T-ODOR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06285708
Behavior, Behavioral Symptoms
Columbus, Ohio, United States
View Trial DetailsNCT07129590
Behavior, Cigarette Smoking
San Francisco, California, United States
View Trial DetailsNCT06941428
Mental Disorders, Psychological Trauma
Seattle, Washington, United States
View Trial DetailsNCT04713722
Behavior, Behavioral Symptoms
Belmont, Massachusetts, United States
View Trial Details